Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 6
1967 4
1968 4
1969 10
1970 5
1971 12
1972 11
1973 10
1974 14
1975 28
1976 17
1977 22
1978 17
1979 31
1980 39
1981 36
1982 58
1983 63
1984 45
1985 68
1986 73
1987 83
1988 77
1989 89
1990 87
1991 87
1992 91
1993 105
1994 75
1995 96
1996 107
1997 99
1998 151
1999 108
2000 97
2001 114
2002 100
2003 97
2004 94
2005 101
2006 101
2007 98
2008 85
2009 70
2010 72
2011 96
2012 91
2013 100
2014 96
2015 108
2016 102
2017 78
2018 74
2019 77
2020 71
2021 86
2022 120
2023 101
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

3,889 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.
Betrosian AP, Frantzeskaki F, Xanthaki A, Douzinas EE. Betrosian AP, et al. J Infect. 2008 Jun;56(6):432-6. doi: 10.1016/j.jinf.2008.04.002. Epub 2008 May 23. J Infect. 2008. PMID: 18501431 Clinical Trial.
OBJECTIVE: To compare the safety and efficacy of ampicillin/sulbactam (Amp/Sulb) and colistin (COL) in the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP). ...Adverse events were 39.6% (including 33% nephrotoxicity) for the CO …
OBJECTIVE: To compare the safety and efficacy of ampicillin/sulbactam (Amp/Sulb) and colistin (COL) in the treatment of multidrug res …
When should old therapies be abandoned? A modern look at old studies on topical ampicillin.
Charalambous CP, Tryfonidis M, Swindell R, Lipsett AP. Charalambous CP, et al. J Infect. 2003 Oct;47(3):203-9. doi: 10.1016/s0163-4453(03)00071-9. J Infect. 2003. PMID: 12963381 Review.
While ampicillin may no longer be an effective agent, topical application of antibiotics is effective.Summary. A meta-analysis of studies using topical ampicillin for the prevention of infection in clean contaminated wound suggests that topical ampicillin is …
While ampicillin may no longer be an effective agent, topical application of antibiotics is effective.Summary. A meta-analysis of stu …
Role of sultamicillin and ampicillin/sulbactam in the treatment of upper and lower bacterial respiratory tract infections.
Lode H. Lode H. Int J Antimicrob Agents. 2001 Sep;18(3):199-209. doi: 10.1016/s0924-8579(01)00387-9. Int J Antimicrob Agents. 2001. PMID: 11673031 Review.
The emergence of beta-lactamase-mediated resistance to beta-lactam antibiotics among key respiratory tract pathogens has threatened the usefulness of the beta-lactam agents familiar to physicians as being clinically effective and well tolerated. This article reassesses the clinic …
The emergence of beta-lactamase-mediated resistance to beta-lactam antibiotics among key respiratory tract pathogens has threatened the usef …
Ampicillin vs. placebo for Yersinia pseudotuberculosis infection in children.
Sato K, Ouchi K, Komazawa M. Sato K, et al. Pediatr Infect Dis J. 1988 Oct;7(10):686-9. doi: 10.1097/00006454-198810000-00003. Pediatr Infect Dis J. 1988. PMID: 3054777 Clinical Trial.
For evaluation of the efficacy of early treatment with ampicillin on the clinical course of Yersinia pseudotuberculosis infection in children, 136 patients were randomly assigned to receive either ampicillin or placebo. ...Ampicillin did not show a clinical b …
For evaluation of the efficacy of early treatment with ampicillin on the clinical course of Yersinia pseudotuberculosis infection in …
Significant Pharmacokinetic Interactions Between Quinine and Ampicillin-Cloxacillin Combination.
Falade OB, Falusi AG, Olaniyi AA, Ezeasor C, Kwasi DA, Babalola CP. Falade OB, et al. Drugs R D. 2016 Jun;16(2):193-203. doi: 10.1007/s40268-016-0128-x. Drugs R D. 2016. PMID: 27020278 Free PMC article. Clinical Trial.

RESULTS: Quinine significantly reduced the rate and extent of excretion of ampicillin and cloxacillin (p < 0.0002). The total amounts of ampicillin and cloxacillin excreted unchanged (Du()) alone were 217.10 53.82 and 199.0 64.29 mg versus 126.40 50.63 and 135.20

RESULTS: Quinine significantly reduced the rate and extent of excretion of ampicillin and cloxacillin (p < 0.0002). The total amou

Ampicillin and sulbactam pharmacokinetics and pharmacodynamics in continuous ambulatory peritoneal dialysis (CAPD).
Blackwell BG, Leggett JE, Johnson CA, Zimmerman SW, Craig WA. Blackwell BG, et al. Perit Dial Int. 1990;10(3):221-6. Perit Dial Int. 1990. PMID: 2099158 Clinical Trial.
The fixed combination antibiotic ampicillin/sulbactam may provide a new, safe, and effective method of treating dialysis-related bacterial peritonitis. ...Ampicillin/sulbactam (2 gm/1 gm) should be administered every 12 h to patients with peritoneal dialysis-related …
The fixed combination antibiotic ampicillin/sulbactam may provide a new, safe, and effective method of treating dialysis-related bact …
Ampicillin dosage and use of prednisolone in treatment of pneumonia: co-operative controlled trial.
McHardy VU, Schonell ME. McHardy VU, et al. Br Med J. 1972 Dec 9;4(5840):569-73. doi: 10.1136/bmj.4.5840.569. Br Med J. 1972. PMID: 4404939 Free PMC article. Clinical Trial.
A controlled trial was carried out to investigate whether the rate of recovery from pneumonia treated with ampicillin is dose related. Sixty-three patients received 1 g ampicillin daily and 63 received 2 g ampicillin daily for seven or 14 days depending on th …
A controlled trial was carried out to investigate whether the rate of recovery from pneumonia treated with ampicillin is dose related …
Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey RD, Rabello YA, Meis PJ, Moawad AH, Iams JD, Van Dorsten JP, Paul RH, Bottoms SF, Merenstein G, Thom EA, Roberts JM, McNellis D. Mercer BM, et al. JAMA. 1997 Sep 24;278(12):989-95. JAMA. 1997. PMID: 9307346 Clinical Trial.
PATIENTS: A total of 614 of 804 eligible gravidas with PPROM between 24 weeks' and 0 days' and 32 weeks' and 0 days' gestation who were considered candidates for pregnancy prolongation and had not received corticosteroids for fetal maturation or antibiotic treatment within 1 week …
PATIENTS: A total of 614 of 804 eligible gravidas with PPROM between 24 weeks' and 0 days' and 32 weeks' and 0 days' gestation who were cons …
The clinical and paraclinical effectiveness of four-hour infusion vs. half-hour infusion of high-dose ampicillin-sulbactam in treatment of critically ill patients with sepsis or septic shock: An assessor-blinded randomized clinical trial.
Mirjalili M, Zand F, Karimzadeh I, Masjedi M, Sabetian G, Mirzaei E, Vazin A. Mirjalili M, et al. J Crit Care. 2023 Feb;73:154170. doi: 10.1016/j.jcrc.2022.154170. Epub 2022 Oct 19. J Crit Care. 2023. PMID: 36272277 Clinical Trial.
PURPOSE: This study was conducted to determine whether critically ill patients admitted to the intensive care unit (ICU) with sepsis and septic shock may benefit from extended infusion of ampicillin/sulbactam compared with those receiving intermittent infusion. MATERIAL AN …
PURPOSE: This study was conducted to determine whether critically ill patients admitted to the intensive care unit (ICU) with sepsis and sep …
Ampicillin/sulbactam versus clindamycin in the treatment of postpartum endomyometritis.
Martens MG, Faro S, Hammill HA, Smith D, Riddle G, Maccato M. Martens MG, et al. South Med J. 1990 Apr;83(4):408-13. doi: 10.1097/00007611-199004000-00012. South Med J. 1990. PMID: 2181689 Clinical Trial.
Sixty-eight patients with postpartum endomyometritis were enrolled in this open randomized comparative study. Forty-two patients received ampicillin/sulbactam and 26 received clindamycin. The cure rates were similar in the two groups: 83% in the ampicillin/sulbactam …
Sixty-eight patients with postpartum endomyometritis were enrolled in this open randomized comparative study. Forty-two patients received …
3,889 results